Navigation Links
Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods for High-Dose Respiratory Disease Therapeutics
Date:2/26/2013

ogical activity of the aerosol.

This technology should have greater acceptance among patients, as it provides for enhanced therapeutic effects, requires a shorter treatment time, and reduces side effects. For pharmaceutical companies, this is a new delivery option with reduced cost of goods (COGS), as they need to use fewer quantities of biologics for effective therapeutic outcomes.

"Due to the inherent disadvantage of existing aerosol delivery systems, most biologics are administered intravenously," observed Darshana. "KAER Biotherapeutics efficiently addresses this issue with an innovative solution that can directly deliver drugs to the lungs and significantly reduce the total dose, cost of therapy, and systemic toxicities."

Each year, Frost & Sullivan presents this award to the company that has demonstrated technological innovation within its industry. This Award recognizes the ability of the company to successfully develop and introduce new/disruptive technology, formulate a well-designed product family, and make significant technology contributions to the industry.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About KAER Biotherapeutics

Clinical research has indicated that inhalation of biotherapeutics is an effective alternative for the treatment of both respiratory and systemic diseases. Aerosol delivery through the respiratory tract is the preferred mode of administration for lung diseases. The ability to deliver these agents directly to the lungs reduces the total dose of the agent, the cost of thera
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
3. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
4. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
5. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
6. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
7. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
11. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3,  2015 About Vision Care ... products considered for this report are Rx lenses, ... products are primarily used by consumer for vision ... Rx lenses and contact lenses require a prescription ... are cosmetic products that can be purchased like ...
(Date:9/3/2015)... 2015 About artificial organs ... are implanted or integrated into individuals to ... artificial heart, kidney, pancreas, and cochlear implants. ... and porous polypropylene), biologics, ceramics, and metals ... organs are incorporated with different technologies like ...
(Date:9/3/2015)... YORK , Sept. 3, 2015 This ... used to save millions of lives across globe. This ... Kingdom of Saudi Arabia . Stakeholders ... material suppliers, government agencies and regulatory bodies. The ... studied from two perspectives: by products and by end ...
Breaking Medicine Technology:Vision Care Market in the US 2015-2019 2Global Artificial Organ Market 2015-2019 2Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... NEW YORK, Dec. 2 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... and Drug Administration (FDA) has granted Fast Track designation ... anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, ... , The Fast Track program of the FDA is ...
... BIRMINGHAM, Ala., Dec. 2 Adults are more likely to ... over, the odds of losing vision are one in three, whereas the ... odds of a woman developing breast cancer are one in nine. ... risk of injuries, depression and inability to complete daily tasks. , Vision ...
Cached Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2
(Date:9/3/2015)... ... September 03, 2015 , ... ... for the Academy of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in Integrative ... Tieraona Low Dog, MD, an internationally renowned educator, physician and thought leader in ...
(Date:9/3/2015)... ... September 03, 2015 , ... Topical BioMedics, ... final destination of his six-month, 10,000 mile journey from Santiago, Chile to Times ... he calls the “Connecting Las Americas” project—Max crossed six countries in 168 days ...
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief ... that professional bull rider David Mason has signed an official endorsement deal with the ... age of six and his first bull at 15. He is an Australian bull ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... the cost of graduated compression garments. However, graduated compression garments are an effective ... care and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS ...
(Date:9/3/2015)... ... September 03, 2015 , ... The first part of a two-part investigative ... IVC filter lawsuits filed against Bard.** These lawsuits, filed by persons and ... filter broke or failed, have recently been consolidated for pretrial proceedings as multidistrict litigation, ...
Breaking Medicine News(10 mins):Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3
... WILMINGTON, N.C., July 29 DiaLog, Inc., ... a joint agreement with DeliverMed,Holdings, LLC, an ... product, the DiaLog System, promotes compliance,and adherence ... patients and their,physicians better manage their disease. ...
... the University of Adelaide have developed a novel approach ... effective with fewer side effects. , Professor Wayne Tilley ... Mitchell Cancer Research Laboratories have discovered that by using ... at lower doses, they can expect to generate better ...
... of allergies such as asthma and hay fever might enjoy ... of New South Wales (UNSW). , In a paper presented ... people with one of these atopic diseases are up to ... of Non-Hodgkin Lymphoma (NHL). , The InterLymph Symposium is co-hosted ...
... Inc.,(Nasdaq: CRDC ) today announced that it will release ... 30, 2008 on Tuesday, August,5, 2008 after the markets close, ... p.m. Eastern Time to discuss the financial results,and provide an ... To access the live conference call on August 5, 2008 ...
... 29 DoctorDirectory.com, Inc.,announced that it ... to,co-market VoSpire ER(R) (Albuterol Sulfate) Extended-Release ... IncreaseRx utilizes,web-based educational and promotional tactics ... prescribers with targeted sales and marketing ...
... Asset Tracking Application Enables, 245-Bed Hospital To Better ... HATBORO, Pa., July 29 InfoLogix, Inc.,(Nasdaq: ... mobility and,advanced wireless asset tracking solutions for the ... been selected by,University Medical Center of Lebanon, TN, ...
Cached Medicine News:Health News:DiaLog Signs Agreement with DeliverMed to Improve Diabetic Patient Management 2Health News:New treatment for advanced prostate cancer 2Health News:Hey fever! The surprise benefit of allergies 2Health News:Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008 2Health News:DoctorDirectory to Co-market VoSpire ER(R) with DAVA Pharmaceuticals, Inc. 2Health News:InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 2Health News:InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 3
...
...
...
... VersaFlex™ UES catheter is made of two ... and choice of sensor distance., ,VersaFlex ... , ,Alpine's VersaFlex catheters are the ... (4.7 French), and are the perfect combination ...
Medicine Products: